Beijing Institute of Biotechnology Team Links miR-148a to HBV-Associated Cancer | GenomeWeb

Researchers from the Beijing Institute of Biotechnology this week published research suggesting that the suppression of a specific microRNA by the hepatitis B virus is responsible for the cancer growth and metastasis that is sometimes caused by the infection.

Although the data were generated in cell culture and in a mouse xenograft model, the findings could point to a new target for cancer treatment, the authors wrote in The Journal of Clinical Investigation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.